David A. Siegel Hille Vax, Inc. Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Hille Vax, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 211,600 shares of HLVX stock, worth $442,243. This represents 0.0% of its overall portfolio holdings.
Number of Shares
211,600
Previous 102,376
106.69%
Holding current value
$442,243
Previous $148,000
184.46%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding HLVX
# of Institutions
70Shares Held
35.7MCall Options Held
0Put Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.6MShares$22.2 Million1.11% of portfolio
-
Tang Capital Management LLC San Diego, CA4.92MShares$10.3 Million0.59% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.42MShares$5.06 Million0.41% of portfolio
-
Black Rock Inc. New York, NY2.09MShares$4.37 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA1.95MShares$4.08 Million0.0% of portfolio
About HilleVax, Inc.
- Ticker HLVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,427,200
- Market Cap $69.9M
- Description
- HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.